NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000001250

Registered date:16/07/2008

Study on the glucocorticoid-sparing effects of tocilizumab among glucocorticoid-dependent patients with adult Still's disease and systemic juvenile idiopathic arthritis: the open trial

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedAdult Still's disease or systemic juvenile idiopathic arthritis
Date of first enrollment2008/07/01
Target sample size10
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Tocilizumab (8 mg/kg of body weight) is to be infused every 2 to 4 weeks.

Outcome(s)

Primary OutcomeAmount of glucocorticoid-dose tapered after tocilizumab-addition
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum16years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteria1. pregnant women or women trying to get pregnant 2. patients with dementia 3. patients considered inappropriate judged by attending physicians

Related Information

Contact

public contact
Name Masahiro Iwamoto
Address Japan
Telephone
E-mail hiro-iwa@jichi.ac.jp
Affiliation Jichi Medical University Division of Rheumatology & Clinical Immunology
scientific contact
Name Masahiro Iwamoto
Address 3311-1 Yakushiji, Shimotsuke, Tochigi Japan
Telephone
E-mail
Affiliation Jichi Medical University Division of Rheumatology & Clinical Immunology